BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5050053)

  • 1. [Experience in the use of a new thymoleptic (34,276-Ba) in the treatment of depressive states].
    Lobova LK; Romel' TE; Igonin AL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):925-9. PubMed ID: 5050053
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problems of differentiated thymoleptic therapy in phasic depressions].
    Smulevich AB; Vorob'ev VIu; Zavidovskaia GI; Lobova EK; Balashova MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(6):912-8. PubMed ID: 4454918
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience with melitracen in the treatment of depressive states].
    Brasseur R
    Schweiz Rundsch Med Prax; 1971 Feb; 60(8):249-53. PubMed ID: 5553886
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with the new antidepressive agent Maprotilin 34'276 Ba].
    Floru L
    Med Welt; 1973 Aug; 24(33):1283-6. PubMed ID: 4764444
    [No Abstract]   [Full Text] [Related]  

  • 5. [New drug for the treatment of depressive syndromes].
    Fiume S
    Clin Ter; 1972 Aug; 62(4):367-76. PubMed ID: 4638878
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of dibencycladine (Ludiomil) and imipramine in the treatment of psychotic depression].
    Roy JY; Pinard G; Hillel J; Gagnon MA; Tétreault L
    Int J Clin Pharmacol; 1973 Feb; 7(1):54-61. PubMed ID: 4699385
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with butriptyline (AY-62014) in the treatment of depressions.
    González M; Montaño H
    J Med; 1971; 2(5):296-9. PubMed ID: 4948364
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of treatment of depressive states with melitracen].
    Madejska N; Mika M; Pańkow T
    Psychiatr Pol; 1967; 1(4):463-71. PubMed ID: 5595168
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of treatment with Melitracen (trausabun) in depressive states].
    Wojdyslawska I
    Psychiatr Pol; 1970; 4(4):449-53. PubMed ID: 5472582
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with maprotyline in endogenous depression.
    Náhunek K; Kamenická V; Rodová A; Svestka J; Misurec J
    Act Nerv Super (Praha); 1973 May; 15(2):108-10. PubMed ID: 4752636
    [No Abstract]   [Full Text] [Related]  

  • 11. EEG changes in treatment with maprotiline.
    Misurec J; Náhunek K; Rodová A
    Act Nerv Super (Praha); 1973 May; 15(2):110. PubMed ID: 4752637
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of LU-3-010 in the treatment of depressive states].
    Zavidovskaia GI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(4):594-8. PubMed ID: 5796678
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary report on the terapeutic activity and clinical as well as biological tolerance of endovenous 34.276 Ba in melancholias and depressive conditions].
    Volmat R; Allers G; Vittouris N; Dufoy F
    Schweiz Arch Neurol Neurochir Psychiatr; 1973; 113(2):410-5. PubMed ID: 4776681
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new antidepressive agent: C 34,276-Ba or maprotyline, 1st tetracyclic thymoanaleptic. Clinical study].
    Nieto Gómez D; Pérez Rincón H
    Prensa Med Mex; 1973; 38(11):429-34. PubMed ID: 4603181
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial of dimethacrine].
    Melo I
    Rev Med Suisse Romande; 1971 Mar; 91(3):183-94. PubMed ID: 5092364
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind, comparative clinical trial with ludiomil (CIBA 34,276-Ba) and amitriptyline in newly admitted depressed patients.
    Amin M; Brahm E; Bronheim LA; Klingner A; Ban TA; Lehmann HE
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):691-9. PubMed ID: 4201313
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of the clinical testing of amitriptylin and C 34,276-Ba (dibenzobicyclooctadiene derivative) in a double-blind study].
    Bruck J; Söllner E; Tschabitscher H
    Nervenarzt; 1974 Sep; 45(9):492-6. PubMed ID: 4612394
    [No Abstract]   [Full Text] [Related]  

  • 18. [Considerations on the therapeutic management of mixed psychoses and of depressive manifestations symptomatic of schizophrenia].
    Scala A
    Osp Psichiatr; 1967; 35(4):501-34. PubMed ID: 5607254
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of clomipramine in psychiatry. Considerations on 4 years' experimentation].
    Scotto JC; Luccioni H; Dufour H; Sutter JM
    Ann Med Psychol (Paris); 1972 May; 1(5):709-14. PubMed ID: 4637059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trial of G 34-586 perfusions in 43 patients].
    Margat P; Broussot T
    Ann Med Psychol (Paris); 1969 Mar; 1(3):461-8. PubMed ID: 5376739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.